Description de l'entreprise
ResMed (NYSE:RMD) changes lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 1 million patients remotely monitored every day.
Conseil d'administration & Conseil de surveillance
| PDG |
| Michael J. Farrell |
| Conseil d'administration |
| Brett Sandercock, Rob Douglas, Lucile Blaise, Bobby Ghoshal, Katrin Pucknat, Justin Leong, Dawn Haake, Vered Keisar, Carlos M. Nunez, Andrew Price, Hemanth Reddy, Michael Rider, Urvashi Tyagi, Amy Wakeham |
| Conseil de surveillance |
| Michael Farrell, Carol J. Burt, Harjit Gill, Jan De Witte, Karen Drexler, Richard Sulpizio, Ronald Taylor, John Hernandez, Desney Tan, Dr. Peter C. Farrell |
Données de l'entreprise
| Nom: |
ResMed Inc. |
| Adresse: |
9001 Spectrum Center Blvd.,San Diego, California 92123, USA |
| Téléphone: |
+1-858-836-5000 |
| Fax: |
+1-858-836-5501 |
| Courriel: |
-
|
| Internet: |
www.resmed.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Medical Products |
| Sous-secteur: |
Advanced Medical Devices |
| Fin de l'exercice financier: |
30/06 |
| Flotte libre: |
73.75% |
| IPO date: |
02/06/1995 |
